Entity family
Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.
Showing 1,981–2,040 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.
…al This study was approved by the Institutional Review Board at The Ohio State University (IRB Nos. 2021C0163, 2021C0145). Given the retrospective nature…
…an TMEs and their influence on immune effector function.Methods Champions Oncology developed an ex vivo, patient-derived 3D co-culture system inco…
… components in a native-like tumor microenvironment.Conclusions Champions Oncology’s HER2-positive CTG3D PDXO platform provides a robust, translat…
…E tissue blocks and clinical information were procured from the Yale University Department of Pathology Archives.Consent Written informed conse…
… data and clinical information from PDAC patients obtained from TCGA and GTEx databases. A six-gene prognostic model based on STs ex…
…is available for review by the Editor of this journal.Reference Jensen TSR, Arendrup MC, von Buchvald C, Frandsen TL, Juhler M, Nygaard U.…
…and clinical data from 448 melanoma patients were obtained from The Cancer Genome Atlas. We analyzed expression and prognostic impact of NLRC3, NLRC4, …
…4 and 201208.1), as well as the Medical Ethics Committee of the University Malaya Medical Centre (Reference no: 842.9). Written informed consent to participatio…
…ained from an independent institutional review board (IRB), the Western Copernicus Group (WCG) (www.wcgclinical.com), under protocol # 1340120. The WCG …
…s spectrometer (ORBITRAP FUSION LUMOS with FAIMS-Pro interface (Thermofisher Scientific). Simultaneously, total RNA-Seq libraries were generated using …
…uced tumor cell necrosis with tumor targeted delivery of IL-12. Cancer Immunol Immunother. 2023;72:2783–2797.Fallon JK, Vandeveer AJ, Schlom J, Greiner J…
… PRISMA-compliant systematic review and meta-analysis. MEDLINE, EMBASE, Scopus and ClinicalTrials.gov were searched (inception-31 May …